Skip to main content

JOHNSON & JOHNSON

corporate_fare Company Profile

JOHNSON & JOHNSON

JNJ·NYSE·Life Sciences·CIK 0000200406

Johnson & Johnson is a global healthcare company with approximately 138,200 employees worldwide. The company focuses on the research, development, manufacturing, and sale of a wide range of products primarily related to human health and well-being. Incorporated in New Jersey in 1887, Johnson & Johnson operates through its subsidiaries in virtually all countries globally. The company is structured into two main business segments: Innovative Medicine and MedTech. The Innovative Medicine segment concentrates on several therapeutic areas. These include Oncology, addressing conditions such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer. In Immunology, the focus is on rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. Neuroscience covers mood disorders, neurodegenerative disorders, and schizophrenia. The segment also addresses Pulmonary Hypertension, specifically Pulmonary Arterial Hypertension, and Infectious Diseases like HIV/AIDS. Additionally, it covers Cardiovascular and Metabolism, including thrombosis, diabetes, and macular degeneration. Products within the Innovative Medicine segment are distributed for prescription use directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals.

JOHNSON & JOHNSON (NYSE:JNJ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 54 items for JNJ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-11, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for JNJ spans 144, 8-K, 10-Q.

Recent high-impact activity:

  • J&J's ACUVUE OASYS MAX 2-Week Lenses Get CE Mark; Axogen Buys BioCircuit for $200M
  • China Approves J&J's Oral Psoriasis Pill Icotrokinra
  • FDA Approves J&J's IMAAVY as First Treatment for Rare Anemia
  • FDA Expands Approval for J&J's Rare Blood Disorder Drug
  • J&J's Monarch Quest 3 Robotic Bronchoscopy Platform Cleared by FDA

Financial Snapshot

Fiscal year ended December 28, 2025
Revenue
$94.19B
Net Income
$26.8B
Diluted EPS
$11.03
Op. Cash Flow
$24.53B
Free Cash Flow
$19.7B
Gross Profit
$63.94B
Cash & Equivalents
$19.71B
Total Debt
$41.44B
Debt / Equity
0.51×
Net Margin
28.5%
Shares Outstanding
2.41B sh
Source: 10-K · filed 2026-02-11 · accession 0000200406-26-000016
Browse all tickers starting with J →
$266.2 +0.62% today
52-week range · as of 2026-08-13 $172.69 – $274.9
Market cap
$640.02B
Volume
4.7M (0.7× avg)
3-mo avg 6.4M
Live data · 2026-09-13 09:25 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed JNJ - Latest Insights

JNJ
Sep 11, 2026, 12:21 PM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $265.90
Real-time Price: $266.20 info
Change: +$0.305 (+0.11%) info
Market Cap: $640.021B info
JNJ
Aug 27, 2026, 4:47 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $273.77
Real-time Price: $266.20 info
Change: -$7.57 (-3%) info
Market Cap: $640.021B info
JNJ
Aug 25, 2026, 8:22 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $271.00
Real-time Price: $266.20 info
Change: -$4.80 (-2%) info
Market Cap: $640.021B info
JNJ
Aug 24, 2026, 6:32 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $273.38
Real-time Price: $266.20 info
Change: -$7.18 (-3%) info
Market Cap: $640.021B info
JNJ
Aug 17, 2026, 8:33 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $259.10
Real-time Price: $266.20 info
Change: +$7.10 (+3%) info
Market Cap: $640.021B info
JNJ
Aug 13, 2026, 2:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $261.49
Real-time Price: $266.20 info
Change: +$4.71 (+2%) info
Market Cap: $640.021B info
JNJ
Aug 05, 2026, 6:07 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $258.24
Real-time Price: $266.20 info
Change: +$7.96 (+3%) info
Market Cap: $640.021B info
JNJ
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $258.35
Real-time Price: $266.20 info
Change: +$7.85 (+3%) info
Market Cap: $640.021B info
JNJ
Jul 30, 2026, 8:41 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $260.52
Real-time Price: $266.20 info
Change: +$5.68 (+2%) info
Market Cap: $640.021B info
JNJ
Jul 29, 2026, 8:52 PM EDT
Source: Binance News
Importance Score:
9
Price at Filing: $260.61
Real-time Price: $266.20 info
Change: +$5.59 (+2%) info
Market Cap: $640.021B info
JNJ
Jul 29, 2026, 5:53 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $261.39
Real-time Price: $266.20 info
Change: +$4.81 (+2%) info
Market Cap: $640.021B info
JNJ
Jul 29, 2026, 5:42 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $262.50
Real-time Price: $266.20 info
Change: +$3.70 (+1%) info
Market Cap: $640.021B info
JNJ
Jul 29, 2026, 5:28 PM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $265.65
Real-time Price: $266.20 info
Change: +$0.5491 (+0.21%) info
Market Cap: $640.021B info
JNJ
Jul 29, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $261.96
Real-time Price: $266.20 info
Change: +$4.24 (+2%) info
Market Cap: $640.021B info
JNJ
Jul 27, 2026, 6:59 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $268.75
Real-time Price: $266.20 info
Change: -$2.55 (-0.95%) info
Market Cap: $640.021B info
JNJ
Jul 27, 2026, 6:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $280.00
Real-time Price: $266.20 info
Change: -$13.80 (-5%) info
Market Cap: $640.021B info
JNJ
Jul 24, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $259.50
Real-time Price: $266.20 info
Change: +$6.70 (+3%) info
Market Cap: $640.021B info
JNJ
Jul 23, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $259.00
Real-time Price: $266.20 info
Change: +$7.20 (+3%) info
Market Cap: $640.021B info
JNJ
Jul 23, 2026, 9:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $257.44
Real-time Price: $266.20 info
Change: +$8.76 (+3%) info
Market Cap: $640.021B info
JNJ
Jul 22, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $252.22
Real-time Price: $266.20 info
Change: +$13.98 (+6%) info
Market Cap: $640.021B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets